TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 13 | 15 | 62 | 45 | 36 | 182 | 59 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/18 17:27 | 10/18/18 | KRYS | Krystal Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Krishnan Krish S | PA | DOT | P,CEO | P | 500 | 20.00 | 0 | 25 | 1 | 4,150 | D | ||||||||||||||
3/19/18 16:43 | 3/19/18 | KRYS | Krystal Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Krishnan Krish S | PA | DOT | P,CEO | P | 550 | 11.00 | 0 | 50 | 1 | 4,033 | D | ||||||||||||||
9/25/17 17:22 | 9/22/17 | KRYS | Krystal Biotech, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Krishnan Krish S | PA | DOT | P,CEO | P.d | 1,000 | 10.00 | 0 | 100 | 3 | 3,983 | M | ||||||||||||||
5/13/14 19:20 | 5/9/14 | XON | Intrexon Corp | VA | Health | Biolab | Commercial Physical & Biologi | Krishnan Krish S | MD | O | COO | P | 297 | 14.21 | 15 | 21 | New | 21 | D | -11 | -46 | -40 | -25 | -14 | 2 | 13 | 15 | 62 | 45 | 36 | 182 | ||
8/11/04 11:02 | 8/10/04 | NRPH | New River Pharmaceuticals Inc | VA | Health | Drug | Pharmaceutical Preparations | Krishnan Krish S | VA | DO | COO,CFO, | P.d | 4 | 8.00 | 0 | 1 | 7 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |